Lymph Node Status and Prognostic Markers in Breast Cancer
Author Information
Author(s): Elzagheid A, Kuopio T, Pyrhönen S, Collan Y
Primary Institution: Turku University Hospital
Hypothesis
The significance of prognosticators in breast cancer varies based on lymph node status.
Conclusion
Mitotic activity indices are the most powerful prognostic markers for both lymph node positive and negative breast cancer patients.
Supporting Evidence
- HER2/neu and E-cadherin are significant prognosticators in lymph node positive patients.
- Proliferation associated prognosticators are valuable in lymph node negative patients.
- Distinguishing between lymph node positive and negative patients is crucial for selecting prognosticators.
Takeaway
Doctors can better predict how breast cancer will behave by looking at whether lymph nodes are affected and which markers are present.
Methodology
Data was collected from various studies to evaluate the significance of different prognosticators in lymph node positive and negative breast cancer patients.
Potential Biases
Most studies do not adjust for age and may not clearly define cutpoints for prognostic markers.
Limitations
Differences in study populations and methodologies make comparisons difficult.
Participant Demographics
Most studied populations are Caucasian, with some studies including a fraction of black patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website